摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

p-Ethylbenzamidine hydrochloride | 29147-96-4

中文名称
——
中文别名
——
英文名称
p-Ethylbenzamidine hydrochloride
英文别名
4-Ethyl-benzamidin-hydrochlorid;p-ethylbenzamidinium chloride;4-Ethylbenzene-1-carboximidamide hydrochloride;4-ethylbenzenecarboximidamide;hydrochloride
p-Ethylbenzamidine hydrochloride化学式
CAS
29147-96-4
化学式
C9H12N2*ClH
mdl
MFCD19381940
分子量
184.669
InChiKey
KVZPICRJHAAEDI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.85
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    49.9
  • 氢给体数:
    3
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    p-Ethylbenzamidine hydrochloride5-氰基-2-氟苯甲醛 在 potassium peroxomonocarbonate 、 4 A molecular sieve 作用下, 以 乙腈 为溶剂, 反应 12.0h, 以69%的产率得到6-Cyano-2-(4-ethylphenyl)quinazoline
    参考文献:
    名称:
    A New Quinazoline Synthesis
    摘要:
    氰基和硝基活化的邻氟苯甲醛与脒类在回流的乙腈中,在K2CO3和4A型粉末分子筛的存在下,进行缩合反应,以良好的收率得到了多种喹唑啉衍生物。
    DOI:
    10.1055/s-1999-2998
  • 作为产物:
    描述:
    4-乙基苯甲腈盐酸 作用下, 以 乙醚乙醇 为溶剂, 反应 59.0h, 生成 p-Ethylbenzamidine hydrochloride
    参考文献:
    名称:
    Understanding Binding Affinity:  A Combined Isothermal Titration Calorimetry/Molecular Dynamics Study of the Binding of a Series of Hydrophobically Modified Benzamidinium Chloride Inhibitors to Trypsin
    摘要:
    The binding of a series of p-alkylbenzamidinium chloride inhibitors to the serine proteinase trypsin over a range of temperatures has been studied using isothermal titration (micro)calorimetry and molecular dynamics simulation techniques. The inhibitors have small structural variations at the para position of the benzamidinium ion. They show small differences in relative binding affinity but large compensating differences in enthalpy and entropy. Binding affinity decreases with increased branching at the first carbon but increases with increasing the length of a linear alkyl substituent, suggesting that steric hindrance and hydrophobic interactions play dominant roles in binding. Structural analysis showed that the backbone of the enzyme was unaffected by the change of the para substituent. In addition, binding does not correlate strongly with octanol/water partition data. To further characterize this system, the change in the heat capacity on binding, the change in solvent-accessible surface area on binding, the effect of inhibitor binding on the hydration of the active site, the pK(a) of His57, and interactions within the catalytic triad have been investigated. Although the changes in inhibitor structure are small, it is demonstrated that simple concepts such as steric hindrance, hydrophobicity, and buried surface area are insufficient to explain the binding data. Other factors, such as access to the binding site and the cost of dehydration of the active site, are of equal or greater importance.
    DOI:
    10.1021/ja034676g
点击查看最新优质反应信息

文献信息

  • Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses
    作者:Vadim A. Makarov、Heike Braun、Martina Richter、Olga B. Riabova、Johannes Kirchmair、Elena S. Kazakova、Nora Seidel、Peter Wutzler、Michaela Schmidtke
    DOI:10.1002/cmdc.201500304
    日期:2015.10
    characterization of pyrazolopyrimidines, a well‐tolerated and potent class of novel EV inhibitors. The compounds inhibit the replication of a broad spectrum of EV in vitro with IC50 values between 0.04 and 0.64 μM for viruses resistant to pleconaril, a known capsid‐binding inhibitor, without affecting cytochrome P450 enzyme activity. Using virological and genetics methods, the viral capsid was identified
    当前尚无可用于治疗由肠病毒(EV)引起的急性和慢性疾病的药物,例如普通感冒,脑膜炎,脑炎,肺炎和心肌炎,伴或不伴连续性扩张性心肌病。在这里,我们报告吡唑嘧啶的发现和表征,吡唑嘧啶是一类耐受性强且有效的新型EV抑制剂。化合物抑制EV的体外广谱与IC的复制50值之间的0.04和0.64μ中号适用于对pleconaril(一种已知的衣壳结合抑制剂)有抗性的病毒,而不会影响细胞色素P450酶的活性。使用病毒学和遗传学方法,病毒衣壳被确定为最有希望的,口服生物利用的化合物3-(4-三甲基苯基)基-6-苯基吡唑并[3,4- d ]嘧啶-4-胺(OBR-5 )的靶标-340)。柯萨奇病毒B3引起的小鼠慢性心肌炎的预防性和治疗性应用都得到了证明。小鼠体内良好的药代动力学,毒理学和药效学特征使OBR-5340成为高度有前途的候选药物,并且正在进行非临床监管计划。
  • Interaction of 2-aryl-4-cyano-1,3-oxazole-5-sulfonyl chlorides with amidines
    作者:A. N. Kornienko、S. G. Pil’o、V. M. Prokopenko、E. B. Rusanov、V. S. Brovarets
    DOI:10.1134/s1070363213070165
    日期:2013.7
    Reaction of 4-cyano-1,3-oxazole-5-sulfonyl chlorides with amidines results in new 7-amino-1,3-oxazolo[5,4-d]pyrimidines. Their structure was confirmed by spectral methods and X-ray diffraction analysis.
  • Biering, A.; Demus, D.; Lichter, L., Molecular Crystals and Liquid Crystals (1969-1991), 1980, vol. 62, p. 1 - 24
    作者:Biering, A.、Demus, D.、Lichter, L.、Sackmann, H.、Wiegeleben, A.、et al.
    DOI:——
    日期:——
  • Synthesis of methyl 2-aryl-5-chlorosulfonyl-1,3-oxazole-4-carboxylates and their reactions with amines and amidines
    作者:A. N. Kornienko、S. G. Pil’o、V. M. Prokopenko、V. S. Brovarets
    DOI:10.1134/s1070363214080210
    日期:2014.8
    Previously unknown methyl 2-aryl-5-chlorosulfonyl-1,3-oxazole-4-carboxylates have been synthesized. Their reactions with amines and amidines have yielded the corresponding sulfonamides and 6H, 7H-[1,3]oxazolo[5,4-d] pyrimidin-7-ones.
  • Kraus, G.; Zaschke, H., Journal fur praktische Chemie (Leipzig 1954), 1981, vol. 323, # 2, p. 199 - 206
    作者:Kraus, G.、Zaschke, H.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫